In relation to that, the well-known day–night rhythmic behaviour of GC levels may also suggest that cell dormancy, as well as chemotherapy response in cancer, is subjected to circadian rhythm through intratumoral GR activity. The gene discussed is NR3C1; the disease is cancer.